Evaluation of Critical Quality Attributes of Immediate Release Ciprofloxacin Tablets of Different Pharmaceutical Companies in Bangladesh

Paroma Arefin¹* , Rezvi Ahmed², Md Shehan Habib¹ , Sreebash Chandra Bhattacharjee¹, Dipankar Chakraborty¹, Suman Das¹, Debabrata Karmakar¹ and Dip Bhowmik¹

¹BCSIR Laboratories, Chattogram, Bangladesh Council of Scientific and Industrial Research (BCSIR), Bangladesh.

²ASA University Bangladesh.

Corresponding Author E-mail: paroma.arefin@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/2883

ABSTRACT:

Critical Quality Attributes (CQAs) is an important factor in Pharmaceutical development as it determines the strength, release of the API from SDFs, and stability of a pharmaceutical dosage form. Moreover, substandard and counterfeit drugs have been a major concern in recent days.Ciprofloxacin is a second-generation fluoroquinolone derivative that exerts its effects by inhibiting bacterial DNA gyrase (Topoisomerase II). It is used for the treatment of bacterial gastroenteritis, respiratory tract infections, controlling bronchitis and pneumonia caused by Gram negative bacteria. Ciprofloxacin has been listed in the World Health Organization (WHO) Model list of Essential Medicines. In recent decades, the pharmaceutical industry has been experiencing excellent growth in both local and international market.In our present study, we have analyzed theCritical Quality Attributes (CQAs) including length, thickness, friability, weight variation, hardness test and disintegration time of Ciprofloxacin tablet to study whether the ciprofloxacin immediate release tablets of different pharmaceutical companies available in the Bangladeshi market to assess whether they are compliant to BP or USP guidelines in respect of physical parameters. We have also performed statistical analysis and found that that all the tablets from different brands are within the BP or USP requirements. So, from the study, we reached the conclusion that the critical quality attributes for ciprofloxacin immediate release tablets of different pharmaceutical companies in Bangladesh ensure the appropriateness of their strength, purity, release of the API from SDFs, and stability.

KEYWORDS: Ciprofloxacin; Critical Quality Attributes; Drug Release; Immediate Release; Stability; Strength

[ HTML Full Text]